Pharm MBA - Poxel SA CEO CoFounder

0RA2 Stock   0.19  0.02  9.52%   

CEO

Pharm MBA is CEO CoFounder of Poxel SA
Address Immeuble Le Sunway, Lyon, France, 69007
Phone33 1 44 71 94 94
Webhttps://www.poxelpharma.com

Poxel SA Management Efficiency

The company has return on total asset (ROA) of (0.9094) % which means that it has lost $0.9094 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.2337) %, meaning that it generated substantial loss on money invested by shareholders. Poxel SA's management efficiency ratios could be used to measure how well Poxel SA manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Poxel SA's Non Currrent Assets Other are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 2.2 M in 2024, whereas Total Assets are likely to drop slightly above 4.6 M in 2024.

Similar Executives

Found 6 records

CEO Age

Colleen KeatingPlanet Fitness Cl
55
David CPAAmerican Homes 4
63
Felix FernandezNaturhouse Health SA
N/A
Michael HSGSynthomer plc
58
David HallasEco Animal Health
60
Christopher RondeauPlanet Fitness Cl
51
Poxel SA (0RA2) is traded on London Exchange in UK and employs 6 people. Poxel SA is listed under Environmental & Facilities Services category by Fama And French industry classification.

Management Performance

Poxel SA Leadership Team

Elected by the shareholders, the Poxel SA's board of directors comprises two types of representatives: Poxel SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Poxel. The board's role is to monitor Poxel SA's management team and ensure that shareholders' interests are well served. Poxel SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Poxel SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Quentin Durand, Chief VP
Pharm MBA, CEO CoFounder
Tejdeep Bawa, VP Development
Fanny Bosa, Vice Administration
Pharm Bolze, COO CoFounder
Sylvie Bertrand, Vice Resources
Pascale MD, CoFounder Affairs
Sophie HallakouBozec, CoFounder Communication
Arthur Rouille, Investor Officer

Poxel Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Poxel SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Poxel Stock Analysis

When running Poxel SA's price analysis, check to measure Poxel SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poxel SA is operating at the current time. Most of Poxel SA's value examination focuses on studying past and present price action to predict the probability of Poxel SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poxel SA's price. Additionally, you may evaluate how the addition of Poxel SA to your portfolios can decrease your overall portfolio volatility.